Le Lézard
Classified in: Health, Science and technology
Subjects: NPT, PER

DR. DOUGLAS WOLF APPOINTED TO CROHN'S AND COLITIS FOUNDATION'S NATIONAL BOARD OF TRUSTEES


Appointment Recognizes a Career of Excellence, Dedication, and Commitment to Patient Care

ATLANTA, May 9, 2024 /PRNewswire/ -- Dr. Douglas Wolf, United Digestive physician and Medical Director for the Center for Crohn's Disease & Ulcerative Colitis, has been appointed to the National Board of Trustees of the Crohn's and Colitis Foundation, the leading nonprofit organization focused on research and patient support for inflammatory bowel disease (IBD).

Dr. Wolf's career spans four decades, during which he has dedicated himself to advancing the understanding and treatment of IBD through clinical practice, research, and patient advocacy. He has conducted extensive clinical research on various aspects of IBD, including diagnostic testing, colonoscopy and capsule endoscopy, and biologic, small molecule, and nutritional therapy. Furthermore, he has lectured extensively, both nationally and internationally, on topics related to IBD and has been an active member of numerous professional medical organizations, including the Crohn's and Colitis Foundation, where he has served on its National Scientific Advisory Committee and in other national leadership roles since 1997.

"I am deeply humbled and honored to accept this appointment to the Crohn's and Colitis Foundation's National Board of Trustees," expressed Dr. Wolf. "Throughout my career, I have witnessed firsthand the profound impact that inflammatory bowel disease can have on individuals and their families. This appointment represents an opportunity to leverage my expertise and passion to drive positive change in the lives of those affected by IBD. I look forward to working collaboratively with my esteemed colleagues on the board."

For more information about Dr. Wolf and United Digestive, please visit www.uniteddigestive.com.

About United Digestive

United Digestive is a leading physician practice management organization serving GI physicians and gastroenterology practices nationwide. Practices that are part of United Digestive benefit from advanced infrastructure and operational insights, along with investments in regional growth. Physician Partners enjoy a dyad leadership model with reduced administrative burden and local support to provide the highest-quality patient care. United Digestive is growing at a rapid pace, with more than 62 clinics, 22 ASCs, and 300 providers practicing in four states ? Georgia, Florida, North Carolina, and South Carolina.

Contact:
Lance Wagner 
Director, Marketing & Communication
[email protected]
404-888-7575 x1130

SOURCE United Digestive


These press releases may also interest you

at 07:40
The "Global Enzyme Contract Manufacturing Market (2024 Edition): Analysis By Source (Plant, Animal, Microbe), By Application, By End-Use, By Region: Market Insights and Forecast (2020-2030)" report has been added to ResearchAndMarkets.com's offering....

at 07:30
Soligenix, Inc. (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need, encourages its eligible stockholders to participate in...

at 07:30
Shoulder Innovations, a leader in the shoulder replacement implant market, is proud to announce the launch of its latest product: the InSettm 95 Humeral Stem. This product is designed to enhance surgical outcomes and improve patient recovery for...

at 07:15
mBIOTA Labs, a medical food company revolutionizing oral nutrition through their proprietary palatable elemental diet, mBIOTA Elementaltm, today announced the initial study results of their first prospective clinical trial assessing the efficacy of...

at 07:15
Epicutis®, a professional, medical-grade luxury skincare line by Signum Biosciences, is thrilled to announce its partnership with the Four Seasons Hotel Toronto along with new Epicutis® Lipid Recovery Mask for Eyes, developed in collaboration with...

at 07:05
Beaconcure Inc., a leader in AI-enabled clinical data validation and automation, announces a strategic partnership with Phastar Inc., a global specialist biometrics contract research organization (CRO), to enhance clinical review processes in...



News published on and distributed by: